
    
      This is a multicenter, randomized, double-blind, comparator-controlled study. The study
      consists of 2 parallel-dose treatment groups consisting of ulimorelin and metoclopramide.
      Approximately 120 mechanically ventilated, tube-fed patients with EFI will participate in
      this trial. To be eligible for study participation, the patients must be intolerant to
      continuous gastric tube feedings, with intolerance defined as having a gastric residual
      volume (GRV) of â‰¥ 500 mL on one or more measurements.
    
  